{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:05:09Z","timestamp":1793034309339,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T00:00:00Z","timestamp":1573603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["CDF-2016-09-014"],"award-info":[{"award-number":["CDF-2016-09-014"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Venous access is a priority for people who inject drugs (PWID). Damage and scarring of peripheral veins can exacerbate health harms, such as skin and soft tissue infections (SSTI), and promote transitions to femoral and subcutaneous injecting. Brown heroin available in Europe requires acidification for injection preparation. In this paper, we present mixed-methods data to explore our hypothesis of a link between overly acidic injection solutions, venous damage and SSTI risk.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We present a structured survey (<jats:italic>n<\/jats:italic>\u00a0=\u2009455) and in-depth qualitative interview (<jats:italic>n<\/jats:italic>\u00a0=\u200931) data generated with PWID in London for the Care &amp; Prevent study. Participants provided life history data and detail on injecting environments and drug preparation practices, including the use of acidifiers. Bivariate and multivariate analyses were conducted using a logistic regression for binary outcomes to explore associations between outcomes and excessive acidifier use. Grounded theory principles informed inductive qualitative analysis. Mixed-methods triangulation was iterative with results comparison informing the direction and questions asked of further analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 455 participants, most (92%) injected heroin and\/or crack cocaine, with 84% using citric as their primary acid for drug preparation. Overuse of acidifier was common: of the 418 who provided an estimate, 36% (<jats:italic>n<\/jats:italic>\u00a0=\u2009150) used more than \u00bd a sachet, with 30% (<jats:italic>n<\/jats:italic>\u2009=\u2009127) using a whole sachet or more. We found associations between acidifier overuse, femoral injecting and DVT, but not SSTI. Qualitative accounts highlight the role of poor heroin quality, crack cocaine use, information and manufacturing constraints in acidifier overuse. Painful injections and damage to peripheral veins were common and often attributed to the use of citric acid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>To reduce injecting-related injury and associated consequences, it is crucial to understand the interplay of environmental and practice-based risks underpinning venous damage among PWID. Overuse of acidifier is a modifiable risk factor. In the absence of structural supports such as safe injecting facilities or the prescribing of pharmaceutical diamorphine, there is an urgent need to revisit injecting paraphernalia design and distribution in order to alleviate health harms and distress among the most marginalised.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12954-019-0330-6","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T19:02:44Z","timestamp":1573671764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Injecting-related health harms and overuse of acidifiers among people who inject heroin and crack cocaine in London: a mixed-methods study"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8718-8226","authenticated-orcid":false,"given":"Magdalena","family":"Harris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talen","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Brathwaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Ciccarone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Hope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,13]]},"reference":[{"issue":"1","key":"330_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12954-018-0233-y","volume":"15","author":"M Harris","year":"2018","unstructured":"Harris M, et al. \u2018Care and Prevent\u2019: rationale for investigating skin and soft tissue infections and AA amyloidosis among people who inject drugs in London. Harm Reduct J. 2018;15(1):23.","journal-title":"Harm Reduct J"},{"issue":"6","key":"330_CR2","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0955-3959(00)00068-2","volume":"11","author":"J Scott","year":"2000","unstructured":"Scott J, et al. Laboratory study of the effects of citric and ascorbic acids on injections prepared with brown heroin. Int J Drug Policy. 2000;11(6):417\u201322.","journal-title":"Int J Drug Policy"},{"key":"330_CR3","volume-title":"Evaluation of the provision of single use citric acid sachets to injecting drug users","author":"J Garden","year":"2003","unstructured":"Garden J, et al. Evaluation of the provision of single use citric acid sachets to injecting drug users. Edinburgh: Effective Interventions Unit, Scottish Executive Drug Misuse Research Programme, University of Paisley; 2003."},{"issue":"7","key":"330_CR4","first-page":"883","volume":"264","author":"S Finberg","year":"2000","unstructured":"Finberg S. Drug abuse: clarification please. Pharm J. 2000;264(7):883.","journal-title":"Pharm J"},{"issue":"12","key":"330_CR5","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/014107689208501204","volume":"85","author":"A Chignell","year":"1992","unstructured":"Chignell A. Endogenous candida endophthalmitis. J R Soc Med. 1992;85(12):721.","journal-title":"J R Soc Med"},{"key":"330_CR6","volume-title":"Drug paraphernalia and UK law","author":"Exchange Supplies","year":"2019","unstructured":"Exchange Supplies. Drug paraphernalia and UK law. 2019; Available from: https:\/\/www.exchangesupplies.org\/article_paraphernalia_and_the_law_introduction.php. Cited 2019 02 February 2019."},{"issue":"1","key":"330_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1477-7517-4-21","volume":"4","author":"CM Beynon","year":"2007","unstructured":"Beynon CM, et al. The impact of citrate introduction at UK syringe exchange programmes: a retrospective cohort study in Cheshire and Merseyside, UK. Harm Reduct J. 2007;4(1):21.","journal-title":"Harm Reduct J"},{"issue":"11","key":"330_CR8","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.drugpo.2015.04.009","volume":"26","author":"D Ciccarone","year":"2015","unstructured":"Ciccarone D, Harris M. Fire in the vein: heroin acidity and its proximal effect on users\u2019 health. Int J Drug Policy. 2015;26(11):1103\u201310.","journal-title":"Int J Drug Policy"},{"key":"330_CR9","unstructured":"Scott J. Study of the safety, risks and outcomes from the use of injecting paraphernalia. Edinburgh: Scottish Executive. 2008.https:\/\/www.webarchive.org.uk\/wayback\/archive\/20170111005205\/ and http:\/\/www.gov.scot\/Publications\/2008\/03\/14133736\/11."},{"key":"330_CR10","unstructured":"Taylor AF, Alex, Rutherford J, Goldberg D. Examining the injecting practices of injecting drug users in Scotland: Scottish Executive, Effective Interventions Unit; 2004. http:\/\/docs.scie-socialcareonline.org.uk\/fulltext\/injectingpracticesfullreport.pdf."},{"issue":"11","key":"330_CR11","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1111\/j.1360-0443.2007.01969.x","volume":"102","author":"T Rhodes","year":"2007","unstructured":"Rhodes T, et al. Crack\u2013heroin speedball injection and its implications for vein care: qualitative study. Addiction. 2007;102(11):1782\u201390.","journal-title":"Addiction"},{"key":"330_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugpo.2015.11.003","volume":"28","author":"VD Hope","year":"2016","unstructured":"Hope VD, et al. Not in the vein: \u2018missed hits\u2019, subcutaneous and intramuscular injections and associated harms among people who inject psychoactive drugs in Bristol, United Kingdom. Int J Drug Policy. 2016;28:83\u201390.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"330_CR13","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1111\/j.1360-0443.2011.03749.x","volume":"107","author":"M Harris","year":"2012","unstructured":"Harris M, Rhodes T. Venous access and care: harnessing pragmatics in harm reduction for people who inject drugs. Addiction. 2012;107(6):1090\u20136.","journal-title":"Addiction"},{"issue":"5","key":"330_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/dar.12359","volume":"35","author":"NM Wright","year":"2016","unstructured":"Wright NM, Allgar V, Tompkins CN. Associations between injecting illicit drugs into the femoral vein and deep vein thrombosis: a case control study. Drug Alcohol Rev. 2016;35(5):605\u201310.","journal-title":"Drug Alcohol Rev"},{"key":"330_CR15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.drugalcdep.2015.03.029","volume":"152","author":"V Hope","year":"2015","unstructured":"Hope V, et al. Going into the groin: injection into the femoral vein among people who inject drugs in three urban areas of England. Drug Alcohol Depend. 2015;152:239\u201345.","journal-title":"Drug Alcohol Depend"},{"key":"330_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.drugalcdep.2016.04.009","volume":"163","author":"D Ciccarone","year":"2016","unstructured":"Ciccarone D, et al. Nationwide increase in hospitalizations for heroin-related soft tissue infections: associations with structural market conditions. Drug Alcohol Depend. 2016;163:126\u201333.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"330_CR17","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1017\/S0950268814000284","volume":"143","author":"V Hope","year":"2015","unstructured":"Hope V, et al. Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England. Epidemiol Infect. 2015;143(1):120\u201331.","journal-title":"Epidemiol Infect"},{"issue":"8","key":"330_CR18","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.3201\/eid2308.170439","volume":"23","author":"D Lewer","year":"2017","unstructured":"Lewer D, Harris M, Hope V. Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997\u20132016. Emerg Infect Dis. 2017;23(8):1400\u20133.","journal-title":"Emerg Infect Dis"},{"issue":"19","key":"330_CR19","first-page":"381","volume":"50","author":"DBJ Ciccarone","year":"2001","unstructured":"Ciccarone DBJ, Kral A, Hobart CJ, Moon A, Edlin BR. Soft tissue infections among injection drug users--San Francisco, California, 1996\u20132000. MMWR Morb Mortal Wkly Rep. 2001;50(19):381.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"330_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0891-5520(02)00017-X","volume":"16","author":"JR Ebright","year":"2002","unstructured":"Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin. 2002;16(3):697\u2013712.","journal-title":"Infect Dis Clin"},{"issue":"4","key":"330_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s11414-009-9177-z","volume":"37","author":"TA Takahashi","year":"2010","unstructured":"Takahashi TA, Maciejewski ML, Bradley K. US hospitalizations and costs for illicit drug users with soft tissue infections. J Behav Health Serv Res. 2010;37(4):508\u201318.","journal-title":"J Behav Health Serv Res"},{"issue":"1","key":"330_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1471-2334-8-120","volume":"8","author":"V Hope","year":"2008","unstructured":"Hope V, et al. Frequency, factors and costs associated with injection site infections: findings from a national multi-site survey of injecting drug users in England. BMC Infect Dis. 2008;8(1):120.","journal-title":"BMC Infect Dis"},{"key":"330_CR23","volume-title":"Shooting up: infections among people who inject drugs in the UK, 2014","author":"Public Health England, H.P.S., Public Health Wales, Public Health Agency Northern Ireland","year":"2015","unstructured":"Public Health England, H.P.S., Public Health Wales, Public Health Agency Northern Ireland. Shooting up: infections among people who inject drugs in the UK, 2014. London: Public Health England; 2015."},{"key":"330_CR24","volume-title":"Designing and conducting mixed methods research","author":"J Creswell","year":"2011","unstructured":"Creswell J, Clark VP. Designing and conducting mixed methods research. Thousand Oaks; London; New Delhi; Singapore: Sage; 2011."},{"issue":"3","key":"330_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/1049732305285708","volume":"16","author":"T Farmer","year":"2006","unstructured":"Farmer T, et al. Developing and implementing a triangulation protocol for qualitative health research. Qual Health Res. 2006;16(3):377\u201394.","journal-title":"Qual Health Res"},{"key":"330_CR26","doi-asserted-by":"crossref","unstructured":"Hartung C, Lerer A, Anokwa Y, Tseng C, Brunette W, et al. Open data kit: Tools to build information services for developing regions, Proceedings of the 4th ACM\/IEEE International Conference on Information and Communication Technologies and Development. 2010. pp. 18. Available at: https:\/\/dl.acm.org\/citation.cfm?id=2369236.","DOI":"10.1145\/2369220.2369236"},{"key":"330_CR27","volume-title":"Constructing grounded theory","author":"K Charmaz","year":"2013","unstructured":"Charmaz K. Constructing grounded theory. London; Thousand Oaks; New Delhi; Singapore: Sage; 2013."},{"issue":"2","key":"330_CR28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11524-011-9664-4","volume":"89","author":"PO Coffin","year":"2012","unstructured":"Coffin PO, et al. Prevalence and characteristics of femoral injection among Seattle-area injection drug users. J Urban Health. 2012;89(2):365\u201372.","journal-title":"J Urban Health"},{"issue":"3","key":"330_CR29","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.drugpo.2008.10.003","volume":"20","author":"Tim Rhodes","year":"2009","unstructured":"Rhodes, T. Risk environments and drug harms: A social science for harm reduction approach. International Journal of Drug Policy. 2009;20(3):193-201.","journal-title":"International Journal of Drug Policy"},{"issue":"1","key":"330_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1177\/1049732311420579","volume":"22","author":"M Harris","year":"2012","unstructured":"Harris M, Treloar C, Maher L. Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res. 2012;22(1):31\u201342.","journal-title":"Qual Health Res"},{"issue":"1","key":"330_CR31","first-page":"7","volume":"9","author":"R Ponton","year":"2004","unstructured":"Ponton R, Scott J. Injection preparation processes used by heroin and crack cocaine injectors. J Subst Abus. 2004;9(1):7\u201319.","journal-title":"J Subst Abus"},{"issue":"3","key":"330_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","volume":"20","author":"D Ciccarone","year":"2009","unstructured":"Ciccarone D. Heroin in brown, black and white: structural factors and medical consequences in the US heroin market. Int J Drug Policy. 2009;20(3):277\u201382.","journal-title":"Int J Drug Policy"},{"key":"330_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.drugpo.2018.11.001","volume":"67","author":"FC Measham","year":"2019","unstructured":"Measham FC. Drug safety testing, disposals and dealing in an English field: exploring the operational and behavioural outcomes of the UK\u2019s first onsite \u2018drug checking\u2019 service. Int J Drug Policy. 2019;67:102\u20137.","journal-title":"Int J Drug Policy"},{"key":"330_CR34","unstructured":"Harris M, Brathwaite R. Care & Prevent: public injecting, wounds and barriers to care, National Needle Exchange Forum Conference. Birmingham; 2018. http:\/\/www.nnef.org.uk\/images\/nnef2018.pdf."},{"key":"330_CR35","first-page":"1","volume-title":"Bournemouth Drug and Alcohol Commissioning Team Newsletter, in Harm minimisation: citric acid","author":"Bournemouth Borough Council","year":"2018","unstructured":"Bournemouth Borough Council. Bournemouth Drug and Alcohol Commissioning Team Newsletter, in Harm minimisation: citric acid; 2018. p. 1\u20137."},{"issue":"4","key":"330_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.drugpo.2012.06.007","volume":"24","author":"M Harris","year":"2013","unstructured":"Harris M. The \u2018do-it-yourself\u2019New Zealand injecting scene: implications for harm reduction. Int J Drug Policy. 2013;24(4):281\u20133.","journal-title":"Int J Drug Policy"},{"key":"330_CR37","volume-title":"How much citric?","author":"Exchange Supplies","year":"2008","unstructured":"Exchange Supplies. How much citric? 2008; Available from: https:\/\/www.youtube.com\/watch?v=e_hlxbW1v20."}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0330-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-019-0330-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0330-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T23:43:18Z","timestamp":1664926998000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-019-0330-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,13]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["330"],"URL":"https:\/\/doi.org\/10.1186\/s12954-019-0330-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,13]]},"assertion":[{"value":"24 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was granted by the London School of Hygiene and Tropical Medicine Observational Research Ethics Committee [12021], the London Bridge Research Ethics Committee and Health Research Authority [17\/LO\/0872]. All participants provided written consent after receiving study information and assurance of confidentiality.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data provided is anonymised. All names attributed to qualitative excerpts are pseudonyms. Qualitative interview participants provided written consent for anonymised narrative excerpts to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}